Bacground: Nauclea latifolia is a medicinal plant used in Côte d'Ivoire as a remedy for tooth decay, dental pain and mouth sores. Its consumption can be toxic. Objective: The aim of this study was to assess the renal, hepatic and myocardial effects, in order to prevent toxicity. Materials and methods: Phytochemistry was carried out by phytochemical screening and thin-layer chromatography. Acute and sub-acute toxicity tests were carried out in accordance with OECD protocols 423 and 407 respectively. Blood samples were taken on days 14 and 28 for analysis of biochemical parameters. Urea was determined using the enzymatic method described by Tietz. Creatinine was determined using the method of Jaffé. Total plasma protein concentration called the “biuret method” developed by Kronh. Alanine aminotransferase activity was determined according to the method recommended by the International Federation of Clinical Chemistry (IFCC). Aspartate aminotransferase (ASAT) activity was determined according to the method of ECCLS. Results: Phytochemistry showed the qualitative and expressive presence of polyphenols, flavonoids, tannins, phenolic acids and saponosides. For acute toxicity, somnolence was reported. No mortality or morbidity was observed. The LD50 was greater than 5000 mg/kg. Blood results showed no temporal disturbance in the functioning of biochemical markers of kidney, liver and heart, but some marginal variations were observed. Conclusion: The non-toxic effect revealed is proportional to the dose and active substances of the aqueous extract of Nauclea latifolia stem bark. This experiment would enable us to formulate improved traditional medicines to help treat oral cavity disorders.
Published in | Advances in Biochemistry (Volume 13, Issue 3) |
DOI | 10.11648/j.ab.20251303.12 |
Page(s) | 79-86 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2025. Published by Science Publishing Group |
Nauclea Latifolia Stem Bark, Toxicity Studies, Phytochemicals, Biochemical Parameters, Biochemical Markers
Parameters | Mean ± SD | Median | Minimum | Maximum | P test |
---|---|---|---|---|---|
CPK | |||||
NT | 2942,91 ± 1364,9 | 2630,5 | 1638 | 5989 | 0,00 |
TT | 957,85 ± 397,3 | 855 | 533 | 2155 | (S) |
LDH | |||||
NT | 4973 ± 7891,9 | 2846 | 1825 | 2999 | 0,10 |
TT | 2477,05 ± 504,7 | 2461,5 | 1610 | 3564 | (NS) |
Protein | |||||
NT | 76 ± 11,64 | 71,50 | 61 | 107 | 0,001 |
TT | 64,05 ± 7, 61 | 63,50 | 47 | 81 | (S) |
TGO | |||||
NT | 327,58 ± 88,20 | 315 | 233 | 514 | 0,08 |
TT | 255,35 ± 120,49 | 228 | 96 | 719 | (NS) |
TGP | |||||
NT | 88,16 ± 30,17 | 79,50 | 55 | 142 | 0,00074 |
TT | 132,0 ± 32,92 | 125,50 | 81 | 221 | (S) |
Albumin | |||||
NT | 42,91 ± 10,60 | 44 | 25 | 60 | 0,06 |
TT | 49,10 ± 6,47 | 49 | 30 | 57 | (NS) |
UREA | |||||
NT | 0,37 ± 0,069 | 0,37 | 0,28 | 0,47 | 0,27 |
TT | 0,40 ± 0,080 | 0,43 | 0,23 | 0,50 | (NS) |
CREAT | |||||
NT | 4,33 ± 0,8876 | 4,00 | 3,00 | 6,00 | 0,74 |
TT | 4,25 ± 0,5501 | 4,00 | 3,00 | 6,00 | (NS) |
Parameters | Mean ± sd | Median | Minimum | Maximum | P test | |
---|---|---|---|---|---|---|
CPK | 0 | 2942,9 ± 1364,9 | 2630 | 1638 | 5989 | 0,0001 (S) |
50 | 886 ± 339,32 | 790,50 | 533 | 1470 | ||
100 | 809,57± 162,97 | 842,0 | 569 | 1066 | ||
200 | 1167,71± 543,27 | 1136 | 596 | 2155 | ||
LDH | 0 | 4973 ± 7891,1 | 2846 | 1825 | 2999 | 0,34 (NS) |
50 | 2426 ± 469,05 | 2493 | 1742 | 2975 | ||
100 | 2376,14 ± 431,3 | 2403 | 1610 | 2865 | ||
200 | 2621,71 ± 631,2 | 2675 | 1956 | 3564 | ||
Protein | 0 | 76 ± 11,64 | 71,50 | 61 | 107 | 0,013 (S) |
50 | 65,33 ± 6,43 | 66 | 55 | 73 | ||
100 | 65,57 ± 7,61 | 65 | 57 | 81 | ||
200 | 61,42 ± 8,88 | 61 | 47 | 71 | ||
TGO | 0 | 327,58 ± 88,20 | 315 | 233 | 514 | 0,0011 (S) |
50 | 226,66 ± 37,72 | 222 | 190 | 296 | ||
100 | 229,14 ± 36,27 | 223 | 190 | 300 | ||
200 | 306,14 ± 197,08 | 264 | 96 | 719 | ||
TGP | 0 | 88,16 ± 30,17 | 79,5 | 55 | 142 | 0,009 (S) |
50 | 139,16 ± 24,02 | 136 | 114 | 172 | ||
100 | 129,14 ± 28,42 | 123 | 97 | 172 | ||
200 | 128,71 ± 45,51 | 124 | 81 | 221 | ||
Albumin | 0 | 42,91 ± 10,60 | 44 | 25 | 60 | 0,3191 (NS) |
50 | 50,50 ± 4,84 | 48,50 | 45 | 57 | ||
100 | 47,0 ± 9,59 | 50,00 | 30 | 57 | ||
200 | 50 ± 3,65 | 49 | 46 | 55 | ||
UREA | 0 | 0,37 ± 0,069 | 0,37 | 0,28 | 0,47 | 0,31 (NS) |
50 | 0,36 ± 0,09 | 0,34 | 0,26 | 0,50 | ||
100 | 0,41 ± 0,08 | 0,44 | 0,23 | 0,50 | ||
200 | 0,42 ± 0,05 | 0,44 | 0,33 | 0,49 | ||
CREAT | 0 | 4,3 ± 0,88 | 4,0 | 3,0 | 6,0 | 0,46 (NS) |
50 | 4,1 ± 0,40 | 4,0 | 4,0 | 5,0 | ||
100 | 4 ± 0,57 | 4,0 | 3,0 | 5,0 | ||
200 | 4,5 ± 0,53 | 5,0, | 4,0 | 5,0 |
Parameters | Mean ± sd | Median | Minimum | Maximum | P test |
---|---|---|---|---|---|
CPK | |||||
0 | 2942,9±1364,9 | 2630 | 1638 | 5989 | 0,000 (S) |
14 | 847,08±441,24 | 699 | 533 | 2155 | |
28 | 1124 ±264,41 | 1101 | 842 | 1470 | |
LDH | |||||
0 | 4973 ± 7891,9 | 2846 | 1825 | 2999 | 0,17 (NS) |
14 | 2392 ± 570,50 | 2354 | 1610 | 3564 | |
28 | 2604 ± 386,27 | 2744 | 1950 | 2975 | |
Protein | |||||
0 | 76 ± 11,64 | 71,5 | 61 | 107 | 0,001 (S) |
14 | 67 ± 753 | 66,5 | 55 | 81 | |
28 | 59,62 ± 5,57 | 61,5 | 47 | 64 | |
TGO | |||||
0 | 327,58±88,20 | 315 | 233 | 514 | 0,007 (S) |
14 | 293,16±138,37 | 242 | 222 | 719 | |
28 | 198,62± 56,50 | 197 | 96 | 306 | |
TGP | |||||
0 | 88,16 ± 30,17 | 79,50 | 55 | 142 | 0,008 (S) |
14 | 124,91± 19,58 | 125,50 | 94 | 162 | |
28 | 142,62± 46,05 | 137,0 | 81 | 221 | |
Albumin | |||||
0 | 42,91 ± 10,60 | 44 | 25 | 60 | 0,14 (NS) |
14 | 48,66 ± 7,01 | 49 | 30 | 56 | |
28 | 49,75 ± 5,99 | 49 | 39 | 57 | |
UREA | |||||
0 | 0,37 ± 0,069 | 0,37 | 0,28 | 0,47 | 0,17 (NS) |
14 | 0,37 0,094 | 0,40 | 0,23 | 0,50 | |
28 | 0,43 0,033 | 0,44 | 0,39 | 0,43 | |
CREAT | |||||
0 | 4,3 ± 0,88 | 4 | 3 | 6 | 0,94 (NS) |
14 | 4,25 ± 0,62 | 4 | 3 | 5 | |
28 | 4,25 ± 4,46 | 4 | 3 | 5 |
OECD | Organisation for Economic Co-operation and Development |
IFCC | International Federation of Clinical Chemistry |
ASAT or TGO | Aspartate Aminotransferase |
ECCLS | European Council for Clinical and Laboratory Standardization |
WHO | World Health Organisation |
CNF | National Center of Floristics |
LD50 | Lethal Dose 50 |
TLC | Thin-layer Chromatography |
CPK | Creatine Phosphokinase |
LDH | Lactate Dehydrogenase |
TP | Total Protein |
ALAT or TGP | Alanine Aminotransferase |
[1] | Adjoungoua, A., Diafouka, F., Koffi, P., Lokrou, A. and Attai, H. (2006) Valorisation de la pharmacopée traditionnelle: Action de l’extrait alcoolique de Bidens pilosa (Asteraceae) sur l’exploration statique et dynamique de la glycémie. Revue de Médecines et Pharmacopées Africaines, 19, 1-12. |
[2] | Aké-AssiL. (2001-2002). Flore de la cote d’Ivoire 1, Catalogue systématique, biblio géographique et écologique. Genève, Conservatoire Botanique Boisseria, p. 441. |
[3] | Arbonnier M. (2002). Arbres, Arbustes et Lianes des Zones Sèches d’Afrique de l’Ouest (2ème Edition). CIRAD, MNHN. |
[4] | Arise RO, Akintola AA, Olarinoye IB, Balogun EA. (2012). Effects of aqueous extract of Nauclea latifolia stem on lipid profile and some enzymes of rat liver and kidney. Int J Pharmacol; 8: 389-395. |
[5] | Badiaga M, (2011). Etude ethnobotanique, phytochimique et activités biologiques de Nauclea latifolia, une plante médicinale africaine récoltée au Mali. Thèse PhD: Université chimie Blaise organique, Pascal-Clermont Ferrand II, p. 253. |
[6] | Bergmeyer HU, Herder M, Rej R. (1985). Approved recommendation on IFCC methods for measurement of catalytic concentration of enzymes. Part 2. IFCC Methods for aspartate aminotransferase. Journal of Clinical Chemistry and Clinical Biochemistry, 24: 497-508. |
[7] | Bidié A, Banga BN, Adou FY, N’guessan JD, Djaman AJ. (2011). Activité antioxydante de dix plantes médicinales de la pharmacopée Ivoirienne. Journal Sciences & Nature, 8 (1): 1-11. |
[8] | Bouquet A, Debray M. (1974). Plantes médicinales de la côte d’Ivoire. Collection «Mémoire de l’ORSTOM», 32: 231. ISBN 2-7099-0341-5. |
[9] | Dick HUB, Sinton J. M. (1979). Compositional layering in Alpine peridotites: Evidence for pressure solution creap in the Mantte. Journal of geology, 87(4): 403-416. |
[10] | ECCLS. (1989). Determination of the catalytic activity concentration in serum of L aspartate amino transferase (EC 2.6.1.1. ASAT). Klin Chem Mitt, 20: 198-204. |
[11] | Groupe de Direction mondiale. (2021). Résistance aux antimicrobiens et crise climatique, Global Leaders Group on antimicrobial resistance. GLG infonote. climate. french. P. 1-4. |
[12] | Grub S, Persohn E, Trommer WE, Wolf A. (2000). Mechanisms of Cyclosporine A Iduced Apoptosis in Rat Hepatocyte Primary Cultures. Toxicol Appl. Pharmacol., 163(3): 209-20. |
[13] | Jaballi I, Ben SH, Bkhairia I, Kammoun I, Droguet M, Magné C. (2017). Increasing maneb doses induces reactive oxygen species overproduction and nephrotoxicity in adult mice. Toxicology Mechanisms and Methods, 27(5): 382 393. |
[14] | Kouadio JH, Mathieu NB, Mama K and Dano S D. (2014). Toxicity of aqueous extract of Nauclea latifolia in Swiss Mice and IN OFA rats. Tropical Journal of Pharmaceutical Research, 13(1): 109 115. |
[15] | Kronh R I. (2011). The colorimetric detection and quantitation of total protein. Current protocols in cell Biology. |
[16] | Murray R. L. (1984). Créatinine. The CV Mosty Co. St Louis Toronto. Princeton Clin Chem, 1261-1266. |
[17] | Organisation de coopération et de développement économique (OCDE). (2001). Lignes directrices pour l’essai des produits chimiques: Toxicité aigüe orale. N° 423. p. 14. |
[18] | Organisation de coopération et de développement économique (OCDE). (2008). Lignes directrices pour l’essai des produits chimiques: Toxicité subaigüe orale à dose répétée pendant 28 jours sur les rongeurs. N° 407. p. 14. |
[19] | Organisation mondiale de la santé (OMS). (2014). Oral health (site internet) Genève. |
[20] | Organisation mondiale de la santé (OMS) / Bureau régional de l’Afrique. (2016). Promouvoir la santé bucco-dentaire en Afrique. p. 121. ISBN: 978-929031223-9 (Classification NLM: WU 140). |
[21] | Porth C. (2015). Essentials of pathophysiology: Concepts of altered heart states Philadelphia, USA 4ème éd. Wolters Kluver. p. 1248. ISBN: 1496309456, 49781496309457. |
[22] | Spencer CON, Sunday JJ, Teslimat EA, Kazeem OA, Eguagie OO, Akinola AA. (2011) Comparative effects of aqueous and ethanolic leaf extracts of Gongronema latgfolium on sen1rn kidney and liver biomarkers of normal male rats. Asian I Biol Sci; 4: 540-547. |
[23] | Stroev EA; Makarova VA. (1989). Quantitative Estimation of Enzymatic Activity. In: Stroev EA, Ed. Laboratory Manual in Biochemistry, 2nd edn, Moscow: Mir Publishers; pp 37-44. |
[24] | Tietz NW. (1999). Textbook of clinical chemistry, 3ème Ed. C. A. Burtis, E. R. Ashwood. W. B Saunder p. 652-656. ISBN: 0721656102, 9780721656106. |
APA Style
Angeline, A. K. M., Ohoueu, H. S. S., Arsène, A. M., Adouko, A. J. A., Bidié, P. A. D., et al. (2025). Photochemistry and Toxicity Studies of Aqueous Nauclea Latifolia Stem Bark Extract: Effect on Serum Biochemical Markers in Wistar Rats. Advances in Biochemistry, 13(3), 79-86. https://doi.org/10.11648/j.ab.20251303.12
ACS Style
Angeline, A. K. M.; Ohoueu, H. S. S.; Arsène, A. M.; Adouko, A. J. A.; Bidié, P. A. D., et al. Photochemistry and Toxicity Studies of Aqueous Nauclea Latifolia Stem Bark Extract: Effect on Serum Biochemical Markers in Wistar Rats. Adv. Biochem. 2025, 13(3), 79-86. doi: 10.11648/j.ab.20251303.12
@article{10.11648/j.ab.20251303.12, author = {Angbo Kousso Marie Angeline and Honoré St Seka Ohoueu and Adon Mousan Arsène and Apoline Jeannette Aka Adouko and Phillipe Alain Dit Bidié and Okpèkon Aboua Timothée}, title = {Photochemistry and Toxicity Studies of Aqueous Nauclea Latifolia Stem Bark Extract: Effect on Serum Biochemical Markers in Wistar Rats }, journal = {Advances in Biochemistry}, volume = {13}, number = {3}, pages = {79-86}, doi = {10.11648/j.ab.20251303.12}, url = {https://doi.org/10.11648/j.ab.20251303.12}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ab.20251303.12}, abstract = {Bacground: Nauclea latifolia is a medicinal plant used in Côte d'Ivoire as a remedy for tooth decay, dental pain and mouth sores. Its consumption can be toxic. Objective: The aim of this study was to assess the renal, hepatic and myocardial effects, in order to prevent toxicity. Materials and methods: Phytochemistry was carried out by phytochemical screening and thin-layer chromatography. Acute and sub-acute toxicity tests were carried out in accordance with OECD protocols 423 and 407 respectively. Blood samples were taken on days 14 and 28 for analysis of biochemical parameters. Urea was determined using the enzymatic method described by Tietz. Creatinine was determined using the method of Jaffé. Total plasma protein concentration called the “biuret method” developed by Kronh. Alanine aminotransferase activity was determined according to the method recommended by the International Federation of Clinical Chemistry (IFCC). Aspartate aminotransferase (ASAT) activity was determined according to the method of ECCLS. Results: Phytochemistry showed the qualitative and expressive presence of polyphenols, flavonoids, tannins, phenolic acids and saponosides. For acute toxicity, somnolence was reported. No mortality or morbidity was observed. The LD50 was greater than 5000 mg/kg. Blood results showed no temporal disturbance in the functioning of biochemical markers of kidney, liver and heart, but some marginal variations were observed. Conclusion: The non-toxic effect revealed is proportional to the dose and active substances of the aqueous extract of Nauclea latifolia stem bark. This experiment would enable us to formulate improved traditional medicines to help treat oral cavity disorders.}, year = {2025} }
TY - JOUR T1 - Photochemistry and Toxicity Studies of Aqueous Nauclea Latifolia Stem Bark Extract: Effect on Serum Biochemical Markers in Wistar Rats AU - Angbo Kousso Marie Angeline AU - Honoré St Seka Ohoueu AU - Adon Mousan Arsène AU - Apoline Jeannette Aka Adouko AU - Phillipe Alain Dit Bidié AU - Okpèkon Aboua Timothée Y1 - 2025/07/18 PY - 2025 N1 - https://doi.org/10.11648/j.ab.20251303.12 DO - 10.11648/j.ab.20251303.12 T2 - Advances in Biochemistry JF - Advances in Biochemistry JO - Advances in Biochemistry SP - 79 EP - 86 PB - Science Publishing Group SN - 2329-0862 UR - https://doi.org/10.11648/j.ab.20251303.12 AB - Bacground: Nauclea latifolia is a medicinal plant used in Côte d'Ivoire as a remedy for tooth decay, dental pain and mouth sores. Its consumption can be toxic. Objective: The aim of this study was to assess the renal, hepatic and myocardial effects, in order to prevent toxicity. Materials and methods: Phytochemistry was carried out by phytochemical screening and thin-layer chromatography. Acute and sub-acute toxicity tests were carried out in accordance with OECD protocols 423 and 407 respectively. Blood samples were taken on days 14 and 28 for analysis of biochemical parameters. Urea was determined using the enzymatic method described by Tietz. Creatinine was determined using the method of Jaffé. Total plasma protein concentration called the “biuret method” developed by Kronh. Alanine aminotransferase activity was determined according to the method recommended by the International Federation of Clinical Chemistry (IFCC). Aspartate aminotransferase (ASAT) activity was determined according to the method of ECCLS. Results: Phytochemistry showed the qualitative and expressive presence of polyphenols, flavonoids, tannins, phenolic acids and saponosides. For acute toxicity, somnolence was reported. No mortality or morbidity was observed. The LD50 was greater than 5000 mg/kg. Blood results showed no temporal disturbance in the functioning of biochemical markers of kidney, liver and heart, but some marginal variations were observed. Conclusion: The non-toxic effect revealed is proportional to the dose and active substances of the aqueous extract of Nauclea latifolia stem bark. This experiment would enable us to formulate improved traditional medicines to help treat oral cavity disorders. VL - 13 IS - 3 ER -